MBL

APOPCYTO Caspase-3 Colorimetric Assay Kit

Product Code:
 
MBL-4800
Product Group:
 
Cell Based Assays
Supplier:
 
MBL
Regulatory Status:
 
RUO
Shipping:
 
dry ice
Storage:
 
-20°C. Please refer to datasheet for additional information
1 / 2
2 / 2

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-4800100 Assays£373.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Description:
Caspases are members of the cysteine aspartic acid-specific protease family, which may be activated by a variety of signals including death receptor ligation, DNA damage, serum starvation, stress, and many more. Active caspases recognize a wide number of different substrates, leading to the activation of several different apoptotic pathways. For example, CAD (caspase-activated deoxyribonuclease), a protein involved in chromatin fragmentation into nucleosome units, is indirectly activated by caspase-3, while ICAD (inhibitor of caspase-activated deoxyribonuclease) is inactivated by caspase-3. The cleavage of several structural proteins by caspases leads to the unique apoptosis cell morphology of chromatin condensation, nucleus fragmentation and cytoplasmic integrity. Detection of caspase activity is recognized as a standard method to measure apoptosis activity. The most common method to measure caspase activity is via the fluorometric or colorimetric detection of the cleavage of caspase-specific substrates.
Gene IDs:
Human: 836 Mouse: 12367
Kit Components:
Cell Lysis Buffer, 2X Reaction Buffer, DTT, Substrate DEVD-pNA, Inhibitor DEVD-FMK, pNA (p-nitroanilide)
Shelf Life:
see label
Target:
Caspase-3

Documents

References

1). Adachi M, et al., Clin Cancer Res, 10, 3853 (2004) 2). Brigotti M, et al., Infect Immun, 75, 2201 (2007) 3). Dinnen RD, et al., J Biol Chem, 282, 26675 (2007) 4). Goga Y, et al., J Dent Res, 85, 240 (2006) 5). Ishii T, et al., Cancer Res, 65, 203 (2005) 6). Madsen-Bouterse SA, et al., Endocrinology, 147, 3826 (2006) 7). Min Y, et al., Gut, 54, 591 (2005) 8). Nozaki N, et al., Circulation, 110, 2869 (2004) 9). Numata K, et al., J Immunol, 178, 3777 (2007) 10). Sinicrope FA, et al., Clin Cancer Res, 10, 8284 (2004)